Retrospective Study
Copyright ©The Author(s) 2024.
World J Gastroenterol. Mar 28, 2024; 30(12): 1714-1726
Published online Mar 28, 2024. doi: 10.3748/wjg.v30.i12.1714
Figure 1
Figure 1 Flow chart of patient selection. CRC: Colorectal cancer; RDW: Red blood cell distribution width.
Figure 2
Figure 2 Kaplan-Meier survival curve for the impact of preoperative red blood cell distribution width on the overall survival of patients in tumor node metastasis stage I-IV. A: Kaplan-Meier survival curve for the impact of preoperative red blood cell distribution width (RDW) on the overall survival (OS) of patients in tumor node metastasis (TNM) stage I; B: Kaplan-Meier survival curve for the impact of preoperative RDW on the OS of patients in TNM stage II; C: Kaplan-Meier survival curve for the impact of preoperative RDW on the OS of patients in TNM stage III; D: Kaplan-Meier survival curve for the impact of preoperative RDW on the OS of patients in TNM stage IV. RDW: Red blood cell distribution width.
Figure 3
Figure 3 Kaplan-Meier survival curve for the impact of preoperative red blood cell distribution width on the disease-free survival of patients in tumor node metastasis stage I-IV. A: Kaplan-Meier survival curve for the impact of preoperative red blood cell distribution width (RDW) on the disease-free survival (DFS) of patients in tumor node metastasis (TNM) stage I; B: Kaplan-Meier survival curve for the impact of preoperative RDW on the DFS of patients in TNM stage II; C: Kaplan-Meier survival curve for the impact of preoperative RDW on the DFS of patients in TNM stage III; D: Kaplan-Meier survival curve for the impact of preoperative RDW on the DFS of patients in TNM stage IV. RDW: Red blood cell distribution width.
Figure 4
Figure 4 Kaplan-Meier survival curve for the impact of preoperative hematocrit on the overall survival of patients in tumor node metastasis stage I-IV. A: Kaplan-Meier survival curve for the impact of preoperative hematocrit on the overall survival (OS) of patients in tumor node metastasis (TNM) stage I; B: Kaplan-Meier survival curve for the impact of preoperative hematocrit on the OS of patients in TNM stage II; C: Kaplan-Meier survival curve for the impact of preoperative hematocrit on the OS of patients in TNM stage III; D: Kaplan-Meier survival curve for the impact of preoperative hematocrit on the OS of patients in TNM stage IV.
Figure 5
Figure 5 Kaplan-Meier survival curve for the impact of preoperative hematocrit on the disease-free survival of patients in tumor node metastasis stage I-IV. A: Kaplan-Meier survival curve for the impact of preoperative hematocrit on the disease-free survival (DFS) of patients in tumor node metastasis (TNM) stage I; B: Kaplan-Meier survival curve for the impact of preoperative hematocrit on the DFS of patients in TNM stage II; C: Kaplan-Meier survival curve for the impact of preoperative hematocrit on the DFS of patients in TNM stage III; D: Kaplan-Meier survival curve for the impact of preoperative hematocrit on the DFS of patients in TNM stage IV.